We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Breathalyzer-Type Device Could Identify Scent in Breath Altered by COVID-19

By LabMedica International staff writers
Posted on 18 Dec 2020
Print article
A breath-testing device similar to a Breathalyzer – which tests blood alcohol levels – could detect COVID-19 immediately with ease and speed, allowing for scores of people to be tested in a short amount of time.

A team of researchers from IUPUI (Indiana University–Purdue University Indianapolis; Indianapolis, IN, USA) is developing a COVID-19 breath-testing device based o the same methodology used in training dogs to sniff out prostate cancer molecules from urine samples. The team is developing a sensor that would identify the scent in breath altered by COVID-19. However, it would be different from how alcohol Breathalyzers work as they measure the level of alcohol in one's breath, which correlates to alcohol in the blood. The researchers are now collecting breath samples from people who have tested positive, including asymptomatically, and negative for COVID-19.

Portable blood-alcohol Breathalyzers that can be attached to a keychain can be purchased online for under USD 50, and the researchers believe that a similar device for COVID-19 could be just as inexpensive once it enters mass production. The team is currently using trained dogs with the capability to sniff out prostate cancer molecules from urine samples, preventing unnecessary biopsies for patients.

"We have the unique perspective of identifying a signature. We're looking at the metabolic pathways the virus causes, which can be identified," said Mangilal Agarwal from the School of Engineering and Technology who is leading the team. "This technology, or proof of it, could help not only with COVID-19 but with other infectious diseases."

Related Links:
IUPUI

Gold Member
COVID-19 TEST READER
COVID-19-CHECK-1 EASY READER+
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.